WO2013046222A3 - A process for the preparation of amorphous rosuvastatin calcium - Google Patents

A process for the preparation of amorphous rosuvastatin calcium Download PDF

Info

Publication number
WO2013046222A3
WO2013046222A3 PCT/IN2012/000526 IN2012000526W WO2013046222A3 WO 2013046222 A3 WO2013046222 A3 WO 2013046222A3 IN 2012000526 W IN2012000526 W IN 2012000526W WO 2013046222 A3 WO2013046222 A3 WO 2013046222A3
Authority
WO
WIPO (PCT)
Prior art keywords
preparation
rosuvastatin calcium
amorphous rosuvastatin
amorphous
calcium
Prior art date
Application number
PCT/IN2012/000526
Other languages
French (fr)
Other versions
WO2013046222A2 (en
Inventor
Sharad Ranganath GORE
Dipak Subhash PATIL
Yogesh KAJALE
Hemant KAMBLE
Srinivas Reddy Sanikommu
Tarun Kant Sharma
Milind Moreshwar Gharpure
Original Assignee
Glenmark Generics Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glenmark Generics Limited filed Critical Glenmark Generics Limited
Publication of WO2013046222A2 publication Critical patent/WO2013046222A2/en
Publication of WO2013046222A3 publication Critical patent/WO2013046222A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom

Abstract

The present invention provides amorphous rosuvastatin calcium having a degree of crystallinity less than about 5% and process for preparation thereof.
PCT/IN2012/000526 2011-08-10 2012-07-27 A process for the preparation of amorphous rosuvastatin calcium WO2013046222A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN2253MU2011 2011-08-10
IN2253/MUM/2011 2011-08-10

Publications (2)

Publication Number Publication Date
WO2013046222A2 WO2013046222A2 (en) 2013-04-04
WO2013046222A3 true WO2013046222A3 (en) 2013-06-20

Family

ID=47996555

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IN2012/000526 WO2013046222A2 (en) 2011-08-10 2012-07-27 A process for the preparation of amorphous rosuvastatin calcium

Country Status (1)

Country Link
WO (1) WO2013046222A2 (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0521471A1 (en) * 1991-07-01 1993-01-07 Shionogi Seiyaku Kabushiki Kaisha Pyrimidine derivatives as HMG-CoA reductase inhibitors
WO2005040134A1 (en) * 2003-10-22 2005-05-06 Ranbaxy Laboratories Limited Process for the preparation of amorphous rosuvastatin calcium
WO2006136408A2 (en) * 2005-06-24 2006-12-28 Lek Pharmaceuticals D.D. Process for preparing pure amorphous rosuvastatin calcium

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0521471A1 (en) * 1991-07-01 1993-01-07 Shionogi Seiyaku Kabushiki Kaisha Pyrimidine derivatives as HMG-CoA reductase inhibitors
WO2005040134A1 (en) * 2003-10-22 2005-05-06 Ranbaxy Laboratories Limited Process for the preparation of amorphous rosuvastatin calcium
WO2006136408A2 (en) * 2005-06-24 2006-12-28 Lek Pharmaceuticals D.D. Process for preparing pure amorphous rosuvastatin calcium

Also Published As

Publication number Publication date
WO2013046222A2 (en) 2013-04-04

Similar Documents

Publication Publication Date Title
GB201019841D0 (en) Calcium sulphate-bases products and methods for the manufacture thereof
ZA201400557B (en) Substituted picolinic acids and pyrimidine-4-carboxylic acids, methods for the production thereof, and use thereof as herbicides and plant growth regulations
PL2630108T3 (en) Process for the preparation of 2,3,3,3 tetrafluoropropene
WO2011138281A3 (en) Process for the preparation of dithiine tetracarboxydiimides
PL2957359T3 (en) Plant for the production of flat rolled products
WO2012068441A3 (en) Intedanib salts and solid state forms thereof
WO2011163452A8 (en) Treating surface of the eye disorders
EP2729464B8 (en) Cyclopropyl-fused-1,3-thiazepines as bace 1 and/or bace 2 inhibitors
WO2012070062A3 (en) Novel polymorph of nilotinib hydrochloride
MX341711B (en) 4-[-2-[[5-methyl-1-(2-naphtalenyl)-1h-pyrazol-3-yl]oxy]ethyl]mor pholine hydrochloride amorphous solid forms.
WO2014048776A3 (en) Water-emulsible isocyanates having improved gloss
WO2010008735A3 (en) Solid states of o-desmethylvenlaf axine salts
IL221461A0 (en) Crystalline forms of the tri-mesylate salt of perphenazine-gaba and process of producing the same
WO2010035284A3 (en) An improved process for the preparation of rosuvastatin calcium
WO2010098583A3 (en) Novel method for preparing statin compounds or salts thereof, and intermediate compounds used in same
EP2693878B8 (en) Substituted (3r,4r)-4-cyan-3,4-diphenylbutanoates, method for the production thereof and use thereof as herbicides and plant growth regulators
WO2012063115A3 (en) Process for the preparation of rosuvastatin calcium via novel amine intermediate
MX2013006867A (en) Method for producing cis-1-ammonium-4-alkoxycyclohexanecarbonitri le salts.
EP3103878A4 (en) Rosuvastatin calcium and process for producing intermediate thereof
HK1223334A1 (en) Process for the manufacture of implants or intermediate products of such implants as well as implants and intermediate products obtained by such process
WO2010109185A3 (en) Process for the preparation of doxazosin and salts thereof
WO2011095985A3 (en) Rasagiline salts and processes for the preparation thereof
WO2014195977A3 (en) Novel polymorphs of vismodegib
HK1189012A1 (en) Compounds, pharmaceutical compositions and a method for the prophylaxis and treatment of the adhesion process
EP2635542A4 (en) Method for the production of fertilizer products from residues

Legal Events

Date Code Title Description
122 Ep: pct application non-entry in european phase

Ref document number: 12835425

Country of ref document: EP

Kind code of ref document: A2